Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

NCT03426371 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
52
Enrollment
INDUSTRY
Sponsor class

Stopped Due to adjustments in our R\&D strategy, we are discontinuing the 140-III-01 study and initiating the 140-III-02 study.

Conditions

Interventions

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.